Physician profile
Heather M Johnson
NPI 1447215785
$30,946.78
in general payments reported to CMS, 2019-2025
11 companies · $3,931 in 2025
The $3,931 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $38.99 · 2023: $3,139 · 2024: $24K · 2025: $3,931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Consulting Fee: $13K · Food and Beverage: $2,172 · Travel and Lodging: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,355.00 |
| Consulting Fee | $13,446.50 |
| Food and Beverage | $2,171.86 |
| Travel and Lodging | $703.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $16,668.59 | 2023-2024 | Nexletol, Nexlizet |
| Novartis Pharmaceuticals Corporation | $6,523.25 | 2023-2025 | |
| Medtronic, INC. | $5,907.50 | 2023-2025 | |
| Amgen INC. | $1,487.46 | 2019-2025 | Repatha |
| Boston Scientific Corporation | $168.96 | 2023 | Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $85.63 | 2020-2023 | |
| Intuitive Surgical, INC. | $35.93 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $32.31 | 2024 | Austedo Xr |
| Exact Sciences Corporation | $18.39 | 2023 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $17.14 | 2019 | |
| Valencia Technologies Corporation | $1.62 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.